Find a Conference

Alert - GRC systems are offline for approximately one week. For more information, please click here.

New Antibacterial Discovery and Development (GRS)

Gordon-Kenan Research Seminar

Enabling the Next Generation of Antibacterial Drugs

March 12 - 13, 2016
Chairs David F. Bruhn and Daniel Hoagland
Renaissance Tuscany Il Ciocco
Via Giovanni Pascoli
Lucca (Barga), Lucca, Italy
 Venue and Travel Information

Conference Description

The Gordon Research Seminar on New Antibacterial Discovery and Development is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.

The discovery and development of new antibiotics to overcome the challenges presented by the rising incidence of drug-resistant bacteria requires the training of outstanding future leaders and the support of a rigorous scientific community. This meeting will enable students and early-career scientists to expand their knowledge and professional network in the field of antibiotic drug discovery and development through a series of research presentations by trainees and a mentorship component led by global experts in the field.

Related Meeting

This GRS will be held in conjunction with the "New Antibacterial Discovery and Development" Gordon Research Seminar (GRS). Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page for more information.

Conference Program

Saturday
1:30 pm - 4:30 pmArrival and Check-in
3:00 pm - 3:15 pmIntroductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair
3:15 pm - 4:00 pmHow to Qualify a Drug Candidate for Development
Discussion Leader: Matthew Surdel (Vanderbilt University, USA)
3:15 pm - 3:50 pmLynn Silver (LL Silver Consulting, LLC, USA)
"How to Qualify a Drug Candidate for Development"
3:50 pm - 4:00 pmDiscussion
4:00 pm - 5:30 pmPoster Session
5:30 pm - 7:30 pmEarly Discovery and Mechanism of Action Studies
Discussion Leaders: Linda Oyama (Aberystwyth University, United Kingdom) and Marina Santiago (Harvard University, USA)
5:30 pm - 5:45 pmRenee Bouley (University of Notre Dame, USA)
"Exploration of the Mechanism of Action and Structure-Activity Relationship for a New Class of Quinazolinone Antibiotics"
5:45 pm - 5:50 pmDiscussion
5:50 pm - 6:05 pmJennifer Stepanek (Ruhr-University Bochum, Germany)
"Dual Mechanism of Action of the Atypical Tetracycline Chelocardin"
6:05 pm - 6:10 pmDiscussion
6:10 pm - 6:25 pmMichaela Wenzel (University of Amsterdam, The Netherlands)
"Reorganization of Fluid Lipid Domains by Daptomycin Inhibits Bacterial Cell Wall Synthesis"
6:25 pm - 6:30 pmDiscussion
6:30 pm - 6:45 pmAshleigh Paparella (The University of Adelaide, Australia)
"Template Guided Synthesis Provides New Antibacterials and Antifungals"
6:45 pm - 6:50 pmDiscussion
6:50 pm - 7:05 pmAndrew Lim (University of Dundee, United Kingdom)
"Mug the Bug: Applying Phenotypic Screening and Metabolomics in the Search for Novel Antibacterials"
7:05 pm - 7:10 pmDiscussion
7:10 pm - 7:25 pmBradley Poulsen (Massachussetts General Hospital / Broad Institute, Harvard Medical School, USA)
"A Multiplexed Chemical Screen of Pseudomonas aeruginosa Hypomorphs Rapidly Identifies Novel Antibiotic Leads"
7:25 pm - 7:30 pmDiscussion
8:00 pmDinner
Sunday
7:30 am - 8:30 amBreakfast
9:00 am - 11:00 amAchieving, Maintaining, and Restoring Compound Efficacy
Discussion Leader: Philip Bulterys (University of California, Los Angeles, USA)
9:00 am - 9:45 amUrsula Theuretzbacher (Center for Anti-Infective Agents, Austria)
"Understanding PK/PD in Early Antibiotic R&D"
9:45 am - 10:00 amDiscussion
10:00 am - 10:15 amBimal Jana (University of Copenhagen, Denmark)
"Gene-Antimicrobial Drug Interactome of MDR Klebsiella pneumoniae ST258"
10:15 am - 10:20 amDiscussion
10:20 am - 10:35 amGiulia Orazi (Geisel School of Medicine, Dartmouth College, USA)
"Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection"
10:35 am - 10:40 amDiscussion
10:40 am - 10:55 amRyan Lamers (McMaster University, Canada)
"Reversing Beta-Lactam Resistance in Pseudomonas aeruginosa: A High-Throughput Screen for Inhibitors of Peptidoglycan Recycling"
10:55 am - 11:00 amDiscussion
11:00 am - 12:30 pmPoster Session

Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pmLunch
1:30 pm - 2:30 pmMentorship Component: Insights from the Industry
Discussion Leader: Miranda Jarrett (St. Jude Children's Research Hospital, USA)
1:30 pm - 2:30 pmPanel Discussion
"Lessons Learned from a Career in Drug Discovery and Development"
  • Michael Dudley (The Medicines Company, USA)
  • Lynn Silver (LL Silver Consulting, LLC, USA)
2:30 pm - 3:00 pmEvaluation Period
Fill in GRS Evaluation Forms
3:00 pmSeminar Concludes

Contributors

Conference Links

Conference History New Antibacterial Discovery and Development
Additional Fee Info



Contact Us

MyGRC Account
Check your application status, complete your registration, update your poster, change your rooming preference, make a bus reservation, print an invitation letter, print a receipt (which includes verification that you are presenting a poster) or print an invoice by logging into your account.

GRC Venues
Everything you need to know, to plan your trip.

FAQs
Instant answers to common questions.

Tell us how we can help

Call us and leave a detailed message at: 401-783-4011

*This voicemail is only checked once daily. Due to high volume of requests during the conference season, responses may be delayed.

You have no notifications